Shares Outstanding (Quarterly) Chart

View Shares Outstanding (Quarterly) for CNBX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shares Outstanding (Quarterly) Chart
Start Trial

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 2007. Start Trial.
Date Value
May 31, 2026 1.476B
February 28, 2026 1.126B
November 30, 2025 753.20M
August 31, 2025 553.96M
May 31, 2025 92.51M
February 28, 2025 33.86M
November 30, 2024 31.11M
August 31, 2024 31.11M
May 31, 2024 31.11M
February 29, 2024 31.11M
November 30, 2023 28.31M
August 31, 2023 22.61M
May 31, 2023 16.03M
February 28, 2023 2.209M
November 30, 2022 1.258M
August 31, 2022 1.239M
May 31, 2022 1.239M
February 28, 2022 1.245M
November 30, 2021 1.239M
August 31, 2021 1.206M
May 31, 2021 1.188M
February 28, 2021 1.127M
November 30, 2020 1.127M
August 31, 2020 1.126M
May 31, 2020 1.126M
Date Value
February 29, 2020 1.125M
November 30, 2019 1.120M
August 31, 2019 1.121M
May 31, 2019 1.120M
February 28, 2019 1.102M
November 30, 2018 1.099M
August 31, 2018 1.013M
May 31, 2018 1.007M
February 28, 2018 1.004M
November 30, 2017 0.9964M
August 31, 2017 0.9962M
May 31, 2017 0.986M
February 28, 2017 0.9556M
November 30, 2016 0.9506M
August 31, 2016 0.8935M
May 31, 2016 0.8919M
February 29, 2016 0.8554M
November 30, 2015 0.8513M
August 31, 2015 0.8459M
May 31, 2015 0.8394M
February 28, 2015 0.8386M
November 30, 2014 0.8386M
May 31, 2014 0.6813M
February 28, 2014 0.348M
November 30, 2013 0.3447M

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
Cocrystal Pharma, Inc. 13.79M
GB Sciences, Inc. --
Arvinas, Inc. 65.30M
Fulcrum Therapeutics, Inc. 76.29M
Definium Therapeutics, Inc. 134.37M